A multicenter phase I–II study of docetaxel plus epirubicin...

The Breast 2013 / 12 Vol. 22; Iss. 6

A multicenter phase I–II study of docetaxel plus epirubicin plus bevacizumab as first-line treatment in women with HER2-negative metastatic breast cancer

Tryfonidis, K., Boukovinas, I., Xenidis, N., Christophyllakis, C., Papakotoulas, P., Politaki, E., Malamos, N., Polyzos, A., Kakolyris, S., Georgoulias, V., Mavroudis, D.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
22
Language:
english
Journal:
The Breast
DOI:
10.1016/j.breast.2013.08.017
Date:
December, 2013
File:
PDF, 348 KB
english, 2013
Conversion to is in progress
Conversion to is failed